CA Stock MarketDetailed Quotes

CTX Crescita Therapeutics Inc

Watchlist
  • 0.550
  • 0.0000.00%
15min DelayMarket Closed Dec 10 16:00 ET
10.51MMarket Cap-3.93P/E (TTM)

Crescita Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
239.20%424K
575.31%547K
-82.26%378K
303.53%2.08M
88.22%-261K
-72.59%125K
1.25%81K
223.37%2.13M
36.13%-1.02M
-372.28%-2.22M
Net income from continuing operations
19.19%-1.04M
-229.54%-926K
-129.30%-626K
-330.39%-1.99M
-112.73%-150K
-757.44%-1.28M
-659.46%-281K
42.41%-273K
178.01%862K
24.92%1.18M
Operating gains losses
-166.67%-24K
---2K
80.00%9K
-96.59%6K
-80.39%10K
-1,000.00%-9K
----
-58.33%5K
2,300.00%176K
--51K
Depreciation and amortization
-17.24%312K
-18.93%304K
2.67%385K
2.38%1.51M
0.53%379K
5.31%377K
1.35%375K
2.46%375K
6.67%1.47M
8.65%377K
Asset impairment expenditure
-52.78%51K
-37.21%81K
62.79%70K
-16.73%438K
-12.71%158K
-36.47%108K
12.17%129K
-28.33%43K
19.55%526K
13.13%181K
Remuneration paid in stock
456.25%89K
-16.92%54K
-4.55%21K
-62.90%82K
-143.75%-21K
-23.81%16K
-14.47%65K
-71.05%22K
-18.75%221K
-60.98%48K
Deferred tax
--0
--0
--0
199.56%456K
143.01%197K
--0
--93K
--166K
-577.08%-458K
---458K
Other non cashItems
123.53%12K
-328.57%-48K
-276.60%-177K
68.93%-32K
124.32%45K
-466.67%-51K
310.00%21K
-146.53%-47K
-239.19%-103K
-372.06%-185K
Change In working capital
5.59%1.02M
437.69%1.08M
-62.17%696K
143.23%1.61M
74.20%-879K
445.00%966K
41.21%-321K
255.21%1.84M
-35.34%-3.72M
-55.00%-3.41M
-Change in receivables
-23.88%1.04M
140.04%1.28M
-131.30%-601K
245.04%3.54M
88.57%-274K
2,822.00%1.36M
547.06%532K
1,423.81%1.92M
-16.41%-2.44M
-1.74%-2.4M
-Change in inventory
-35.92%-912K
6,700.00%66K
568.46%996K
48.48%-917K
52.87%-394K
-195.59%-671K
98.94%-1K
123.92%149K
-29.45%-1.78M
-416.67%-836K
-Change in payables and accrued expense
109.20%887K
92.52%-75K
216.00%348K
-654.74%-1.29M
-50.55%-408K
1,866.67%424K
-177.84%-1M
-133.78%-300K
-76.64%232K
-179.38%-271K
-Change in other current assets
106.08%9K
-221.85%-184K
-166.20%-47K
-0.73%271K
103.09%197K
-804.76%-148K
439.29%151K
-44.09%71K
202.25%273K
1,177.78%97K
Cash from discontinued investing activities
Operating cash flow
239.20%424K
575.31%547K
-82.26%378K
303.53%2.08M
88.22%-261K
-72.59%125K
1.25%81K
223.37%2.13M
36.13%-1.02M
-372.28%-2.22M
Investing cash flow
Cash flow from continuing investing activities
-2,592.86%-754K
-912K
0
54.14%-133K
-41.89%-105K
-1,300.00%-28K
0
0
65.72%-290K
66.67%-74K
Net PPE purchase and sale
-2,592.86%-754K
---912K
--0
41.92%-133K
-707.69%-105K
-1,300.00%-28K
--0
--0
33.82%-229K
94.14%-13K
Net business purchase and sale
----
----
----
--0
----
----
----
----
---61K
----
Cash from discontinued investing activities
Investing cash flow
-2,592.86%-754K
---912K
--0
54.14%-133K
-41.89%-105K
-1,300.00%-28K
--0
--0
65.72%-290K
66.67%-74K
Financing cash flow
Cash flow from continuing financing activities
29.94%-227K
-56.44%-158K
-138.38%-236K
57.64%-782K
-16.74%-258K
-19.12%-324K
91.48%-101K
41.07%-99K
-269.20%-1.85M
-13.92%-221K
Net issuance payments of debt
-6.80%-110K
-8.91%-110K
-9.09%-108K
70.28%-408K
-6.06%-105K
-11.96%-103K
90.74%-101K
-8.79%-99K
-293.41%-1.37M
-11.24%-99K
Net common stock issuance
51.25%-117K
---48K
---78K
8.39%-393K
-112.50%-153K
-33.33%-240K
--0
--0
-324.75%-429K
-30.91%-72K
Proceeds from stock option exercised by employees
--0
----
----
216.67%19K
--0
--19K
----
----
--6K
--0
Net other financing activities
----
----
---50K
----
----
----
----
----
0.00%-50K
----
Cash from discontinued financing activities
Financing cash flow
29.94%-227K
-56.44%-158K
-138.38%-236K
57.64%-782K
-16.74%-258K
-19.12%-324K
91.48%-101K
41.07%-99K
-269.20%-1.85M
-13.92%-221K
Net cash flow
Beginning cash position
-11.87%9.01M
-7.24%9.53M
13.92%9.39M
-27.30%8.24M
-6.68%10.02M
-2.63%10.23M
-12.49%10.28M
-27.30%8.24M
-20.66%11.33M
-12.24%10.74M
Current changes in cash
-145.37%-557K
-2,515.00%-523K
-93.01%142K
136.79%1.16M
75.14%-624K
-224.73%-227K
98.43%-20K
355.61%2.03M
-7.24%-3.16M
-183.62%-2.51M
Effect of exchange rate changes
-177.27%-17K
113.79%4K
-20.00%4K
-122.22%-14K
-220.00%-12K
-59.26%22K
-185.29%-29K
114.29%5K
1,000.00%63K
150.00%10K
End cash Position
-15.80%8.44M
-11.87%9.01M
-7.24%9.53M
13.92%9.39M
13.92%9.39M
-6.68%10.02M
-2.63%10.23M
-12.49%10.28M
-27.30%8.24M
-27.30%8.24M
Free cash from
-520.62%-408K
-550.62%-365K
-82.26%378K
255.56%1.94M
83.57%-366K
-78.63%97K
191.01%81K
247.07%2.13M
35.72%-1.25M
-222.43%-2.23M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 239.20%424K575.31%547K-82.26%378K303.53%2.08M88.22%-261K-72.59%125K1.25%81K223.37%2.13M36.13%-1.02M-372.28%-2.22M
Net income from continuing operations 19.19%-1.04M-229.54%-926K-129.30%-626K-330.39%-1.99M-112.73%-150K-757.44%-1.28M-659.46%-281K42.41%-273K178.01%862K24.92%1.18M
Operating gains losses -166.67%-24K---2K80.00%9K-96.59%6K-80.39%10K-1,000.00%-9K-----58.33%5K2,300.00%176K--51K
Depreciation and amortization -17.24%312K-18.93%304K2.67%385K2.38%1.51M0.53%379K5.31%377K1.35%375K2.46%375K6.67%1.47M8.65%377K
Asset impairment expenditure -52.78%51K-37.21%81K62.79%70K-16.73%438K-12.71%158K-36.47%108K12.17%129K-28.33%43K19.55%526K13.13%181K
Remuneration paid in stock 456.25%89K-16.92%54K-4.55%21K-62.90%82K-143.75%-21K-23.81%16K-14.47%65K-71.05%22K-18.75%221K-60.98%48K
Deferred tax --0--0--0199.56%456K143.01%197K--0--93K--166K-577.08%-458K---458K
Other non cashItems 123.53%12K-328.57%-48K-276.60%-177K68.93%-32K124.32%45K-466.67%-51K310.00%21K-146.53%-47K-239.19%-103K-372.06%-185K
Change In working capital 5.59%1.02M437.69%1.08M-62.17%696K143.23%1.61M74.20%-879K445.00%966K41.21%-321K255.21%1.84M-35.34%-3.72M-55.00%-3.41M
-Change in receivables -23.88%1.04M140.04%1.28M-131.30%-601K245.04%3.54M88.57%-274K2,822.00%1.36M547.06%532K1,423.81%1.92M-16.41%-2.44M-1.74%-2.4M
-Change in inventory -35.92%-912K6,700.00%66K568.46%996K48.48%-917K52.87%-394K-195.59%-671K98.94%-1K123.92%149K-29.45%-1.78M-416.67%-836K
-Change in payables and accrued expense 109.20%887K92.52%-75K216.00%348K-654.74%-1.29M-50.55%-408K1,866.67%424K-177.84%-1M-133.78%-300K-76.64%232K-179.38%-271K
-Change in other current assets 106.08%9K-221.85%-184K-166.20%-47K-0.73%271K103.09%197K-804.76%-148K439.29%151K-44.09%71K202.25%273K1,177.78%97K
Cash from discontinued investing activities
Operating cash flow 239.20%424K575.31%547K-82.26%378K303.53%2.08M88.22%-261K-72.59%125K1.25%81K223.37%2.13M36.13%-1.02M-372.28%-2.22M
Investing cash flow
Cash flow from continuing investing activities -2,592.86%-754K-912K054.14%-133K-41.89%-105K-1,300.00%-28K0065.72%-290K66.67%-74K
Net PPE purchase and sale -2,592.86%-754K---912K--041.92%-133K-707.69%-105K-1,300.00%-28K--0--033.82%-229K94.14%-13K
Net business purchase and sale --------------0-------------------61K----
Cash from discontinued investing activities
Investing cash flow -2,592.86%-754K---912K--054.14%-133K-41.89%-105K-1,300.00%-28K--0--065.72%-290K66.67%-74K
Financing cash flow
Cash flow from continuing financing activities 29.94%-227K-56.44%-158K-138.38%-236K57.64%-782K-16.74%-258K-19.12%-324K91.48%-101K41.07%-99K-269.20%-1.85M-13.92%-221K
Net issuance payments of debt -6.80%-110K-8.91%-110K-9.09%-108K70.28%-408K-6.06%-105K-11.96%-103K90.74%-101K-8.79%-99K-293.41%-1.37M-11.24%-99K
Net common stock issuance 51.25%-117K---48K---78K8.39%-393K-112.50%-153K-33.33%-240K--0--0-324.75%-429K-30.91%-72K
Proceeds from stock option exercised by employees --0--------216.67%19K--0--19K----------6K--0
Net other financing activities -----------50K--------------------0.00%-50K----
Cash from discontinued financing activities
Financing cash flow 29.94%-227K-56.44%-158K-138.38%-236K57.64%-782K-16.74%-258K-19.12%-324K91.48%-101K41.07%-99K-269.20%-1.85M-13.92%-221K
Net cash flow
Beginning cash position -11.87%9.01M-7.24%9.53M13.92%9.39M-27.30%8.24M-6.68%10.02M-2.63%10.23M-12.49%10.28M-27.30%8.24M-20.66%11.33M-12.24%10.74M
Current changes in cash -145.37%-557K-2,515.00%-523K-93.01%142K136.79%1.16M75.14%-624K-224.73%-227K98.43%-20K355.61%2.03M-7.24%-3.16M-183.62%-2.51M
Effect of exchange rate changes -177.27%-17K113.79%4K-20.00%4K-122.22%-14K-220.00%-12K-59.26%22K-185.29%-29K114.29%5K1,000.00%63K150.00%10K
End cash Position -15.80%8.44M-11.87%9.01M-7.24%9.53M13.92%9.39M13.92%9.39M-6.68%10.02M-2.63%10.23M-12.49%10.28M-27.30%8.24M-27.30%8.24M
Free cash from -520.62%-408K-550.62%-365K-82.26%378K255.56%1.94M83.57%-366K-78.63%97K191.01%81K247.07%2.13M35.72%-1.25M-222.43%-2.23M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data